Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AstraZeneca AB
AB
Active
Org 5560117482
Forskargatan 18, 151 36
Södertälje
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 1913 · 112 years old
7543 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
AstraZeneca AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
59B
117B
176B
235B
107.3B
2020
114.1B
2021
165.2B
2022
181.5B
2023
204.1B
2024
EBITDA
SEK millions
51535M
38651M
25768M
12884M
0M
31366M
2020
19462M
-38%
2021
23019M
+18%
2022
35598M
+55%
2023
41228M
+16%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
107 280 000
114 063 000
165 242 000
181 475 000
204 149 000
Staff expenses
—
—
—
—
—
EBITDA
31 366 000
19 462 000
23 019 000
35 598 000
41 228 000
Depreciation & amort.
—
—
—
—
—
EBIT
31 366 000
19 462 000
23 019 000
35 598 000
41 228 000
Net financials
4 519 000
3 559 000
−44 264 000
47 157 000
22 454 000
Profit before tax
28 543 000
16 731 000
−23 093 000
84 424 000
50 860 000
Tax
−7 560 000
−3 640 000
−5 882 000
−12 711 000
−7 998 000
Net profit
20 983 000
13 091 000
−28 975 000
71 713 000
42 862 000
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
317 093 000
316 065 000
270 063 000
365 256 000
446 798 000
Equity
213 168 000
209 309 000
159 334 000
262 803 000
305 665 000
Long-term debt
15 924 000
17 576 000
13 497 000
13 314 000
31 045 000
Short-term debt
23 722 000
20 259 000
24 951 000
24 273 000
39 899 000
Total debt
39 646 000
37 835 000
38 448 000
37 587 000
70 944 000
Financial ratios
5-year trend
EBITDA margin
20.2%
This company
15.8%
Market median
+28% vs market
2020
2024
Equity ratio
68.4%
This company
38.2%
Market median
+79% vs market
2020
2024
Return on equity
14.0%
This company
18.4%
Market median
+24% vs market
2020
2024
Net profit margin
21.0%
This company
8.1%
Market median
+159% vs market
2020
2024
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
2020
2024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on AstraZeneca AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
